Vanderbilt University is part of a national effort to improve diabetes treatment by developing strategies for proliferating, regenerating and improving the function of insulin-producing beta cells in the pancreatic islets.

The Vanderbilt Diabetes Center is celebrating two significant milestones this month.

Keith Yamamoto, Ph.D., an international leader in the study of signaling and gene regulation by intracellular receptors, will deliver the next Flexner Discovery Lecture on Thursday, Oct. 10.

Last week, 130 students from more than 75 medical schools across the nation were at Vanderbilt to take part in the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Medical Student Research Symposium, sponsored by the National Institutes of Health and organized by the Vanderbilt Diabetes Center.